Uploaded October 2026 | Updated November 2026, 2 days ago
New tools provide an optogenetic switch for G proteins, how two immune-suppression treatments lower or raise the risk of complications in recipients of stem cell transplants, and a new “digital twin” framework shows that two out of nine FDA-approved drugs have the potential to treat preterm labor: check out new covers from #ScienceSignaling, #ScienceTranslationalMedicine, and #ScienceAdvances.
Learn more: https://scim.ag/4hzTTAQ
CREDITS: MÜCHER ET AL./SCIENCE SIGNALING; N. BURGESS/SCIENCE TRANSLATIONAL MEDICINE; CLARA LEIBENGUTH
#Science #ScienceShorts
New tools provide an optogenetic switch for G proteins, how two immune-suppression treatments lower or raise the risk of complications in recipients of stem cell transplants, and a new “digital twin” framework shows that two out of nine FDA-approved drugs have the potential to treat preterm labor: check out new covers from #ScienceSignaling, #ScienceTranslationalMedicine, and #ScienceAdvances.
Learn more: https://scim.ag/4hzTTAQ
CREDITS: MÜCHER ET AL./SCIENCE SIGNALING; N. BURGESS/SCIENCE TRANSLATIONAL MEDICINE; CLARA LEIBENGUTH
#Science #ScienceShorts










